Delivery Order SPE2DB24D2003-SPE2DB25FXMZ8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Telmisartan 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,555.12. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $8,254.14 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Telmisartan 20 mg tablets (30-count) valued at $11,635.07. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,630.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on August 18, 2025, with completion targeted for August 19, 2025. This non-set-aside contract was competitively awarded to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,260.65 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count package). This competitively awarded, firm fixed-price contract was executed on September 10, 2025, with an ultimate completion date of September 11, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 40 mg tablets (30-count) with a ceiling value of $3,852.25 under a firm fixed-price contract structure. The award was made on June 16, 2025, with an ultimate completion date of June 17, 2025, and represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Telmisartan 40 mg tablets (quantity 30) valued at $3,000.96. This competitive award, with no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026). The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Telmisartan 40 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded delivery order has a ceiling value of $3,822.24 and is structured as a firm fixed price contract with an ultimate completion date of August 18, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on August 4, 2025, with a ceiling value of $3,660.86 and an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and represents a delivery order under...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMZ8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,918.34 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside, firm fixed-price contract was awarded competitively and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of pharmaceutical products to military and veteran healthcare systems. This delivery order for the antihypertensive medication Telmisartan exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through its global pharmaceutical supply vehicle. The underlying IDC enables flexible procurement of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, with the Defense Logistics Agency planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 9/19/25 |